I tried to get onto the trails in the UK a year go before I started treatment (but missed out on the dates).

Trials are still going on and it looks interesting, thay are based in Oxford UK and in the USA.

Regards

Tony


Head & Neck cancer

The Company has completed a Phase I/II study in the first line treatment of head & neck cancer in combination with chemo radiation. It was observed that there was a clear correlation between the dose of OncoVEX used and the rate of complete pathological response at surgery. No patient receiving treatment with OncoVEX has recurred locally in the head & neck region to date. The Company intends to meet with the FDA in the second half of 2008 to seek agreement on the design of a second pivotal Phase III clinical trial to be governed by a SPA in recurrent head & neck cancer. Only 50% of patients with recurrent head & neck cancer survive one year, even when treated with aggressive multi drug chemotherapy.